Complementary meds sector sore over new law

Organisation: Position: Deadline Date: Location:

The signing of the Medicines and Related Substances Amendment Bill 6 of 2014 into law by President Jacob Zuma has natural health and complementary medicines as well as traditional healer’s organisations in an uproar, reports The Citizen.

“This new Act creates a new legal framework for the Medicines Control Council (MCC) to be scrapped, and for the establishment of a new South African Health Products Regulatory Authority (SAHPRA), similar to the FDA in the US,” said Anthony Rees of the Traditional and Natural Health Alliance. He claimed the new structure would no longer be an organ of state, but a self-funded, autonomous, semi-private entity at an arm’s length from the South African legislature.

The other problem was, Rees said, the definition of complementary and alternative products – and African traditional medicines – was dropped from the text of the Bill during its passage through parliament.

The report says with about 250,000 practitioners in South Africa and about 70,000 on its books, the Traditional Healers Organisation of South Africa national coordinator Phephsile Maseko was not surprised traditional healers had been left out of Bill 6. “The MCC never helped us promote African traditional medicine, nor did it do anything for the development of allied health professionals, instead it concentrated a lot on Western drugs,” Maseko said. “So now we are saying it cannot be we support Bill 6 and we do not want to be part of this legislation because it does not represent our interests.”

Maseko said the replacing of the MCC by SAPHRA showed how little regard government had for traditional medicine and wondered how government would protect intellectual property gained by healers over eons. “Through Bill 6 all that information will be exposed to the pharmaceutical industry, how is government going to protect us now?”

Norman Fels of the Health Products Association of South Africa said in the report there was “legitimate concern” from the industry SAHPRA would only be populated by representatives of big pharma. “It might be dominated by big pharma, when one doesn’t have a transparent process and accountability; there is always an element of discomfort,” said Fels before cautioning against generalising that big pharmaceutical companies were all against complementary medicines.

“There are some large companies with a huge investment in complementary medicine and I think because they are looking at the gross figures globally, it’s not a bad market to be in.

“So I’m not sure they would want to strangle it. What they might do is see an opportunity – let’s call it an entry barrier – where if the bar is set very high the smaller companies which won’t have a full time registration pharmacist and the like, and will find it difficult to survive.

“So we are hoping the regulations are not too onerous and the registrations are not too extensive and the timelines are not too long.”

Rees said since legislation had been enacted in 2013 for complementary medicine producers to register their medicines, only 15 had complied out of a possible 20,000 and not one application had been processed by the MCC.

Rees said regulation was needed in the industry. He is quoted in the report as saying: “We would like to see regulation for natural products which protect the public, that the products are safe, are of good quality, and that was it says on the label is in the bottle.

“We’d also like to see the efficacy of the product guaranteed to some degree, bearing in mind the health claims are the biggest problem for the regulators. Many of these products have been used for hundreds if not thousands of years however because they haven’t gone through scientific scrutiny yet, the Westernised drug model is now been imposed on natural products.”

Rees pointed out that SAHPRA would also become a springboard for the Pan-African ‘Model Law for Pharmaceuticals’, a harmonised regulatory regime hatched last year by the African Medicines Regulatory Harmonisation Programme, implemented as part of the Pharmaceutical Manufacturing Plan for Africa.

Full report in The Citizen

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.